Skip to main content
. 2024 Apr 10;16(8):1117. doi: 10.3390/nu16081117

Table 1.

Baseline characteristics of all groups.

Controls ACD Seropositive ACD Seronegative GFD Potential CD
TOTAL 411 203 14 195 15
Sex: n [%] M: 121 [30]
F: 289 [70]
M: 54 [27]
F: 149 [73]
M: 4 [29]
F: 10 [71]
M: 56 [29]
F: 139 [71]
M: 4 [36]
F: 11 [64]
Age (years)
Median 41 36 44 39 35
(min/max)
Q1/Q3
(17/88)
31/50
(17/83)
26/47
(20/90)
26/66
(17/85)
27/52
(19/68)
31/42
Villous atrophy n [%]
Marsh 0 353 [85.9] 0 0 129 [66.2] 9 [60]
Marsh I 57 [13.9] 0 0 34 [17.4] 3 [20]
Marsh II 1 [0.2] 0 0 3 [1.5] 3 [20]
Marsh III A, B, C 0 203 [100] 14 [100] 29 [14.9] 0
Serology n [%]
Positive 0 194 [95.5] 0 [0] 9 [4.6] 15 [100]
Negative 412 [100] 0 14 [100] 112 [57.4] 0
Not available 0 9 [4.5] 0 [0] 74 [38.0] 0
HLA allele n [%]
DQ2 or DQ8 92 [22.3] 114 [56.1] 12 [85.7] 115 [59.0] 11 [73.3]
Nor DQ2 or DQ8 41 [10.3] 2 [1.0] 0 [ 1 [0.5] 0
Not available 277 [67.4] 87 [42.9] 2 [14.3] 79 [40.5] 4 [26.7]

ACD, active celiac disease; CD, celiac disease; GFD, gluten-free diet; F, female; M, male.